Abstract:We read with interest the article by Ye and colleagues [1Ye B. Cheng M. Li W. et al.Predictive factors for lymph node metastasis in clinical stage Ia lung adenocarcinoma.Ann Thorac Surg. 2014; 98: 217-223Abstract Full Text Full Text PDF PubMed Scopus (74) Google Scholar] about the predictive factors for lymph node metastasis in clinical stage IA lung adenocarcinoma, in which they reported a 10.6% overall rate of lymph node metastasis.Theoretically, candidates for sublobar resection should be node negative; thus, it is important to improve the accuracy of clinical staging for cancer. According to the data of Ye and colleagues, factors such as ground-glass opacity status, serum carcinoembryonic antigen level, histologic subtype, and maximum standardized uptake value have potential for the prediction of lymph node metastasis. A prediction model based on some of these factors has been established to assess the possibility of lymph node metastasis in early-stage lung cancer [2Zhang Y. Sun Y. Xiang J. Hu H. Chen H. A prediction model for n2 disease in T1 non-small cell lung cancer.J Thorac Cardiovasc Surg. 2012; 144: 1360-1364Abstract Full Text Full Text PDF PubMed Scopus (56) Google Scholar]. Some issues are worth noting here. First, the specific histology subtype (eg, acinar predominant, micropapillary predominant) was a reliable predictive factor both in the study of Ye and colleagues and in other research [3Zhang Y. Sun Y. Shen L. et al.Predictive factors of lymph node status in small peripheral non-small cell lung cancers: tumor histology is more reliable.Ann Surg Oncol. 2013; 20: 1949-1954Crossref PubMed Scopus (47) Google Scholar]. However, for the majority of lung cancer patients, the histology subtype is a postoperative pathologic diagnosis that is difficult to determine before operation because of the lack of a sufficient tumor specimen, so the histology subtype is of limited value for excluding node-positive patients preoperatively. Second, according to their univariate analyses, the node metastasis rates for patients with individual risk factors were less than 20%, suggesting that these predictive factors are insufficiently efficient for excluding node-positive patients.Two approaches have potential value in selecting candidates for sublobar resection. One is to identify high-risk patients for lymph node metastasis, followed by mediastinal staging evaluation. The other is the use of lymphatic tracers for sentinel lymph node mapping. A clinical study has demonstrated that an indocyanine green fluorescence imaging system is feasible for use in sentinel node biopsy and has a high overall accuracy rate of 80.7% [4Yamashita S. Tokuishi K. Anami K. et al.Video-assisted thoracoscopic indocyanine green fluorescence imaging system shows sentinel lymph nodes in non-small-cell lung cancer.J Thorac Cardiovasc Surg. 2011; 141: 141-144Abstract Full Text Full Text PDF PubMed Scopus (69) Google Scholar]. Optimization of the imaging system and lymphatic tracers for the sentinel lymph nodes would provide an accurate means of determining the optimal candidates for sublobar resection. We eagerly await the further development and refinement of this technology.Again, we congratulate Ye and colleagues on this brilliant study. We are confident that this study will optimize the selection of candidates for either invasive mediastinal staging or sublobar resection. We read with interest the article by Ye and colleagues [1Ye B. Cheng M. Li W. et al.Predictive factors for lymph node metastasis in clinical stage Ia lung adenocarcinoma.Ann Thorac Surg. 2014; 98: 217-223Abstract Full Text Full Text PDF PubMed Scopus (74) Google Scholar] about the predictive factors for lymph node metastasis in clinical stage IA lung adenocarcinoma, in which they reported a 10.6% overall rate of lymph node metastasis. Theoretically, candidates for sublobar resection should be node negative; thus, it is important to improve the accuracy of clinical staging for cancer. According to the data of Ye and colleagues, factors such as ground-glass opacity status, serum carcinoembryonic antigen level, histologic subtype, and maximum standardized uptake value have potential for the prediction of lymph node metastasis. A prediction model based on some of these factors has been established to assess the possibility of lymph node metastasis in early-stage lung cancer [2Zhang Y. Sun Y. Xiang J. Hu H. Chen H. A prediction model for n2 disease in T1 non-small cell lung cancer.J Thorac Cardiovasc Surg. 2012; 144: 1360-1364Abstract Full Text Full Text PDF PubMed Scopus (56) Google Scholar]. Some issues are worth noting here. First, the specific histology subtype (eg, acinar predominant, micropapillary predominant) was a reliable predictive factor both in the study of Ye and colleagues and in other research [3Zhang Y. Sun Y. Shen L. et al.Predictive factors of lymph node status in small peripheral non-small cell lung cancers: tumor histology is more reliable.Ann Surg Oncol. 2013; 20: 1949-1954Crossref PubMed Scopus (47) Google Scholar]. However, for the majority of lung cancer patients, the histology subtype is a postoperative pathologic diagnosis that is difficult to determine before operation because of the lack of a sufficient tumor specimen, so the histology subtype is of limited value for excluding node-positive patients preoperatively. Second, according to their univariate analyses, the node metastasis rates for patients with individual risk factors were less than 20%, suggesting that these predictive factors are insufficiently efficient for excluding node-positive patients. Two approaches have potential value in selecting candidates for sublobar resection. One is to identify high-risk patients for lymph node metastasis, followed by mediastinal staging evaluation. The other is the use of lymphatic tracers for sentinel lymph node mapping. A clinical study has demonstrated that an indocyanine green fluorescence imaging system is feasible for use in sentinel node biopsy and has a high overall accuracy rate of 80.7% [4Yamashita S. Tokuishi K. Anami K. et al.Video-assisted thoracoscopic indocyanine green fluorescence imaging system shows sentinel lymph nodes in non-small-cell lung cancer.J Thorac Cardiovasc Surg. 2011; 141: 141-144Abstract Full Text Full Text PDF PubMed Scopus (69) Google Scholar]. Optimization of the imaging system and lymphatic tracers for the sentinel lymph nodes would provide an accurate means of determining the optimal candidates for sublobar resection. We eagerly await the further development and refinement of this technology. Again, we congratulate Ye and colleagues on this brilliant study. We are confident that this study will optimize the selection of candidates for either invasive mediastinal staging or sublobar resection. Predictive Factors for Lymph Node Metastasis in Clinical Stage IA Lung AdenocarcinomaThe Annals of Thoracic SurgeryVol. 98Issue 1PreviewSystematic lymph node dissection or sampling in all patients with clinical stage IA lung adenocarcinoma is currently controversial because the risk of lymph node metastasis is unclear. This study aimed to determine the predictive factors for lymph node metastasis in patients with clinical stage IA lung adenocarcinoma. Full-Text PDF

Which definition of a central tumour is more predictive of occult mediastinal metastasis in nonsmall cell lung cancer patients with radiological N0 disease?

Distribution and prognosis of mediastinal lymph node metastases of nonsmall cell lung cancer.

Prediction Mode of More Than 5 Central Lymph Nodes Metastases in Clinically Node-Negative Ipsilateral Papillary Thyroid Carcinoma with Tumor Size 1 to 4 Cm

The Incidence And Predictive Factors For Central Lymph Node Metastasis In Unilateral Papillary Thyroid Carcinoma

Indications for invasive mediastinal staging in patients with early non-small cell lung cancer staged with PET-CT

Predictive Risk Factors for Lymph Node Metastasis in Patients with Small Size Non-Small Cell Lung Cancer.

Optimal Lung Cancer Candidates for Sublobar Resection: Prediction of Pathologic Node-Negative Clinical Stage IA NSCLC.

Risk Factors for Occult Nodal Metastasis in Patients with Stage ⅠA Peripheral Non-Small Cell Lung Cancer

Multiparametric evaluation of mediastinal lymph node metastases in clinical T0-T1c stage non-small-cell lung cancers

Risk Analyses of N2 Lymph-Node Metastases in Patients with T1 Non-Small Cell Lung Cancer: a Multi-Center Real-World Observational Study in China

Tumor Histology Predicts Mediastinal Nodal Status and May Be Used to Guide Limited Lymphadenectomy in Patients with Clinical Stage I Non–small Cell Lung Cancer

Predicting Non-Small-volume Central Lymph Node Metastases (>5 or ≥2 Mm) Preoperatively in Cn0 Papillary Thyroid Microcarcinoma Without Extrathyroidal Extension

The pattern of lymph node metastasis in peripheral pulmonary nodules patients and risk prediction models

Predictive factors for non-small-volume central lymph node metastases (more than 5 or ≥ 2 mm) in clinically node-negative papillary thyroid carcinoma.

Risk Factors for Predicting the Occult Nodal Metastasis in T1–2N0M0 NSCLC Patients Staged by PET/CT: Potential Value in the Clinic

Clinicopathological and computed tomographic features associated with occult lymph node metastasis in patients with peripheral solid non-small cell lung cancer

A Prediction Model for N2 Disease in T1 Non-small Cell Lung Cancer: Implications for Cost-effective Mediastinal Staging

Limitations of PET/CT in the Detection of Occult N1 Metastasis in Clinical Stage I(T1-2aN0) Non-Small Cell Lung Cancer for Staging Prior to Stereotactic Body Radiotherapy

Impact of imaging features on selecting limited lymph node resection for cT1N0M0 lung cancer

Enlarged Mediastinal Lymph Nodes in Computed Tomography Are a Valuable Prognostic Factor in Non-Small Cell Lung Cancer Patients with Pathologically Negative Lymph Nodes

Predictors of Lymph Node Metastasis and Possible Selective Lymph Node Dissection in Clinical Stage IA Non-Small Cell Lung Cancer